Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC K-Dur Supreme Court Appeal

This article was originally published in The Pink Sheet Daily

Executive Summary

The U.S. Supreme Court has asked the Solicitor General to submit a brief concerning a case between Schering-Plough and the Federal Trade Commission regarding Schering's settlement with Upsher-Smith over K-Dur generics

You may also be interested in...



Unsettling Settlements: FTC Alarmed By Increasing Brand/Generic Deals

The Federal Trade Commission notes the threat of authorized generics, as well as its appeals court loss in the K-Dur case, as reasons for the jump in settlements.

Unsettling Settlements: FTC Alarmed By Increasing Brand/Generic Deals

The Federal Trade Commission notes the threat of authorized generics, as well as its appeals court loss in the K-Dur case, as reasons for the jump in settlements.

Bristol/Apotex’ Plavix Settlement Is Challenged

Kroger supermarket chain files a civil antitrust lawsuit charging that the settlement is a “horizontal agreement not to compete.”

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS061198

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel